Naturally acquired antibodies to merozoite surface protein (MSP)-1 19 and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 8, 2007, Pages 943-951

  Ladeia Andrade, Simone ^a   Ferreira, Marcelo Urbano ^b   Scopel, Kézia Katiani Gorza ^c   Braga, Érika Martins ^c   Bastos, Melissa Da Silva ^b   Wunderlich, Gerhard ^b   Coura, José Rodrigues ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Amazon; Malaria; Merozoite surface protein 1; Transmission rates

Indexed keywords

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 38149112423     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000800009     Document Type: Article

References (29)

1. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172: 379-382.
2. Blackman MJ, Ling IT, Nicholls SC, Holder AA 1991. Proteolytic processing of the Plasmodium falciparum merozoites surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol 49: 29-34.
3. Braga EM, Barros RM, Reis TA, Fontes CJ, Morais CG, Martins MS, Krettli AU 2002. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg 66: 461-466.
4. Branch OL, Oloo AJ, Nahlen BL, Kaslow D, Lal AA 2000. Antimerozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age. V. The Asembo Bay Cohort Project. J Infect Dis 181: 1746-1752.
5. Burattini MN, Massad E, Coutinho FA 1993. Malaria transmission rates estimated from serological data. Epidemiol Infect 111: 503-523.
6. de Oliveira CI, Wunderlich G, Levitus G, Soares IS, Rodrigues MM, Tsuji M, del Portillo HA 1999. Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax. Vaccine 17: 2959-2968.
7. del Portillo HA, Longacre S, Khouri E, David P 1991. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc Natl Acad Sci USA 88: 4033-4034.
8. Dodoo DT, Theander T, Kurtzals J, Koram K, Riley E, Akanmori BD, Nkrumah F, Hviid L 1999. Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein-1 in Ghanaian children not associated with protection from clinical malaria. Infect Immun 67: 2131-2137.
9. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WMM, Lemnge MM, Cox J, Reyburn H, Riley EM 2005. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA 102: 5108-5113.
10. Egan AF, Morris J, Barnish G, Allen S, Greewood BM, Kaslow DC, Holder AA, Riley EM 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa c-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173: 765-769.
11. Ferreira MU, Ribeiro WL, Tonon AP, Kawamoto F, Rich SM 2003. Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum. Gene 304: 65-75.
12. Funasa - Fundação Nacional de Saúde 2001. Manual de Terapêutica da Malária, Brasília, p. 104.
13. Gatton M, Hogarth W, Saul A, Dayananda P 1996. A model for predicting the transmission rate of malaria from serological data. J Math Biol 34: 878-888.
14. Han HJ, Park CG, Kim SH, Hwang SY, Jin Han, Traico J, Kho WG, Chung JY 2004. Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion. Biochem Biophys Res Commun 320: 63-570.
15. John CC, O'Donnell RA, Sumba PO, Moormann AM, Koning-Wa TF, King CL, Kazura JW, Crabb BS 2004. Evidence that invasion-inhibitory antibodies specific for the 19 kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area Africa. J Immunol 173: 666-672.
16. Kaslow DC, Hui G, Kumar S 1994. Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1 19) variants secreted from Saccharomyces cerevisiae. Mol Biochem Parasitol 63: 283-289.
17. Kimura M, Kaneko O, Liu Q, Zhou M, Kawamoto F, Wataya Y, Otani S, Yamaguchi Y, Tanabe K 1997. Identification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene. Parasitol Internat 46: 91-95.
18. Ladeia-Andrade S, Ferreira UM, Carvalho ME, Curado I, Coura JR. Age-dependent acquisition of protective immunity to malaria among riverine populations of the Amazon Basin of Brazil. Trans R Soc Trop Med Hyg (in press).
19. Miller LH, Roberts T, Shahabuddin M, McCutchan TF 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol 59: 1-14.
20. Morais CG, Soares IS, Carvalho LH, Fontes CJ, Krettli AU, Braga EM 2005. IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Parasitol Res 95: 420-426.
21. 19 are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 193: 1403-1412.
22. Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K 2002. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci USA 99: 16348-16353.
23. Riley EM, Wagner GE, Ofori MF, Wheeler JG, Akanmori BD, Tetteh K, McGuinness D, Bennett S, Nkrumah FK, Anders RF, Koram KA 2000. Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 68: 5856-5863.
24. Soares IS, Barnwell JW, Ferreira MU, Da Cunha MG, Laurino JP, Castilho BA, Rodrigues MM 1999a. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol Med 5: 459-470.
25. Soares IS, Cunha MG, Silva MN, Souza JM, Del Portillo HA, Rodrigues MM 1999b. Longevity of the naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax MSP1. Am J Trop Med Hyg 60: 357-363.
26. Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM 1997. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun 65: 1606-1614.
27. Soares IS, Oliveira SG, Souza JM, Rodrigues MM 1999c. Antibody response to the N and C-terminal regions of the Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of Plasmodium vivax malaria in the north of Brazil. Acta Trop 72: 13-24.
28. Tanabe K, Mackay M, Goman M, Scaife JG 1987. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J Mol Biol 195: 273-283.
29. Win TT, Lin K, Mizuno S, Zhou M, Liu Q, Ferreira MU, Tantular IS, Komija S, Ishii A, Kawamoto F 2002. Wide distribution of Plasmodium ovale in Myanmar. Trop Med Int Health 7: 231-239.